SCHEMBL15568544

SCHEMBL15568544

O=C(NC1CCN(c2nc3ccccc3n2Cc2cccc(F)c2)CC1)C1CCCCC1

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 7/20 0.54
HRH1 P35367 7/20 0.54
CHRM1 P11229 3/20 0.54
ACKR3 P25106 4/20 0.49
MAPT P10636 3/20 0.48
MEN1 O00255 1/20 0.48
ALDH1A1 P00352 1/20 0.48
GAA P10253 1/20 0.48
HTT P42858 1/20 0.48
KMT2A Q03164 1/20 0.48
KCNH2 Q12809 3/20 0.48
TP53 P04637 2/20 0.47
SIGMAR1 Q99720 1/20 0.47
PDE6D O43924 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15567155 0.86 SIGMAR1 (0.65) CYP2D6HRH1CHRM1MAPTMEN1
SCHEMBL15569117 0.84 MEN1 (0.48) CYP2D6HRH1CHRM1MAPTMEN1
SCHEMBL15568307 0.84 KMT2A (0.59) CYP2D6HRH1CHRM1MAPTALDH1A1
SCHEMBL15568581 0.82 HRH1 (0.49) CYP2D6HRH1CHRM1MAPTMEN1
SCHEMBL31633065 0.82 HRH1 (0.55) CYP2D6HRH1CHRM1MAPTHTT
SCHEMBL15567597 0.82 HRH1 (0.54) CYP2D6HRH1CHRM1HTTKCNH2
SCHEMBL31633134 0.81 HRH1 (0.57) CYP2D6HRH1CHRM1HTTKCNH2
SCHEMBL15568271 0.79 PDE6D (0.56) CYP2D6HRH1CHRM1MAPTMEN1
SCHEMBL15569414 0.79 HRH1 (0.56) CYP2D6HRH1CHRM1GAAHTT
Trifluoroacetic Acid SCHEMBL15567418 0.79 HRH1 (0.59) CYP2D6HRH1CHRM1KCNH2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014027053-A1 BENZIMIDAZOLES FOR THE TREATMENT OF CANCER MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-02-20 WO claimed
WO-2014027053-A1 BENZIMIDAZOLES FOR THE TREATMENT OF CANCER MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-02-20 WO disclosed